Vifor Fresenius Medical Care Renal Pharma Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Joint Venture

  • Financing Rounds
  • 1

  • Investments
  • 1

Vifor Fresenius Medical Care Renal Pharma General Information

Description

Supplier of iron replacement products for use in dialysis. The company engages in the development and worldwide distribution of drugs for kidney patients. It also specializes in manufacturing nephrology medicines.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Rechenstrasse 37 P.O. Box
  • 9001 Saint Gallen
  • Switzerland
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • Rechenstrasse 37 P.O. Box
  • 9001 Saint Gallen
  • Switzerland

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vifor Fresenius Medical Care Renal Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Vifor Fresenius Medical Care Renal Pharma‘s full profile, request access.

Request a free trial

Vifor Fresenius Medical Care Renal Pharma Patents

Vifor Fresenius Medical Care Renal Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4175743-A1 Manufacturing method for polynuclear iron compounds stabilized by carbohydrates and/or humic acid Pending 01-Jul-2020
AU-2021302614-A1 Manufacturing method for polynuclear iron compounds stabilized by carbohydrates and/or humic acid Pending 01-Jul-2020
EP-3932535-A1 Manufacturing method for polynuclear iron compounds stabilized by carbohydrates and/or humic acid Inactive 01-Jul-2020
CA-3182581-A1 Manufacturing method for polynuclear iron compounds stabilized by carbohydrates and/or humic acid Pending 01-Jul-2020
US-20230174568-A1 Manufacturing method for polynuclear iron compounds stabilized by carbohydrates and/or humic acid Pending 01-Jul-2020 C07H23/00
To view Vifor Fresenius Medical Care Renal Pharma’s complete patent history, request access »

Vifor Fresenius Medical Care Renal Pharma Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Vifor Fresenius Medical Care Renal Pharma‘s full profile, request access.

Request a free trial

Vifor Fresenius Medical Care Renal Pharma Investments (1)

Vifor Fresenius Medical Care Renal Pharma’s most recent deal was a PIPE with Chemocentryx for . The deal was made on 04-Jan-2018.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Chemocentryx 04-Jan-2018 PIPE Pharmaceuticals
To view Vifor Fresenius Medical Care Renal Pharma’s complete investments history, request access »

Vifor Fresenius Medical Care Renal Pharma Exits (1)

Vifor Fresenius Medical Care Renal Pharma’s most recent exit was on 04-Jan-2018 from Chemocentryx. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Chemocentryx 04-Jan-2018 Completed
To view Vifor Fresenius Medical Care Renal Pharma’s complete exits history, request access »

Vifor Fresenius Medical Care Renal Pharma FAQs

  • When was Vifor Fresenius Medical Care Renal Pharma founded?

    Vifor Fresenius Medical Care Renal Pharma was founded in 2010.

  • Where is Vifor Fresenius Medical Care Renal Pharma headquartered?

    Vifor Fresenius Medical Care Renal Pharma is headquartered in Saint Gallen, Switzerland.

  • What industry is Vifor Fresenius Medical Care Renal Pharma in?

    Vifor Fresenius Medical Care Renal Pharma’s primary industry is Drug Discovery.

  • Is Vifor Fresenius Medical Care Renal Pharma a private or public company?

    Vifor Fresenius Medical Care Renal Pharma is a Private company.

  • What is Vifor Fresenius Medical Care Renal Pharma’s current revenue?

    The current revenue for Vifor Fresenius Medical Care Renal Pharma is .

  • Who are Vifor Fresenius Medical Care Renal Pharma’s investors?

    CSL Vifor and Fresenius Medical Care have invested in Vifor Fresenius Medical Care Renal Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »